Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 29.06.2026 1 Acta Neuropathol 1 AJNR Am J Neuroradiol 1 Arch Pathol Lab Med 4 BMC Cancer 1 BMC Neurol 1 Cancer 3 Childs Nerv Syst 20 J Neurooncol 1 J Neuropathol Exp Neurol 2 J Neurosurg 4 Neuro Oncol 1 Neurol Clin Pract 2 Neuroradiology 3 Neurosurgery 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. BRAMAN BC, Aggarwal A, Nguyen MP, Mirchia K, et al
   Risk stratification for meningiomas with discordant molecular classification.
   Acta Neuropathol. 2026;151:70.
   PubMed        
   
   

   
   AJNR Am J Neuroradiol

2. BAGHERI S, Familiar AM, Adib Moradi S, Fathi Kazerooni A, et al
   Quantitative Impact of T1 Subtraction Maps on Enhancing Component Delineation and Measured Volumes in Minimally Enhancing Pediatric Brain Tumors.
   AJNR Am J Neuroradiol. 2026 Jun 24:ajnr.A9497. doi: 10.3174/ajnr.A9497.
   PubMed         Abstract available
   
   

   
   Arch Pathol Lab Med

3. FERNANDES IL, Abdullaev Z, Quezado M, Aldape K, et al
   Molecular Classification of Central Nervous System Tumors in Developing Countries: Challenges, Opportunities, and Feasibility in a Pathology Reference Laboratory.
   Arch Pathol Lab Med. 2026;150:548-558.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. PENG Z, Wang Y, Qi Y, Hu H, et al
   Application of prediction model based on CT radiomics in prognosis of patients with non-small cell lung cancer.
   BMC Cancer. 2025;25:1273.
   PubMed         Abstract available
   
   
5. JIN K, Qu Y, Li S, Sun C, et al
   A survival prediction model for leptomeningeal metastasis patients with non-small cell lung cancer based on deep learning.
   BMC Cancer. 2025 Dec 28. doi: 10.1186/s12885-025-15503.
   PubMed        
   
   
6. KHALED H, Mosaab A, Taha H, Refaat A, et al
   Descriptive and molecular analysis of pineal parenchymal tumors with clinical correlation.
   BMC Cancer. 2025;26:100.
   PubMed         Abstract available
   
   
7. DELABY C, Al Herk A, Hirtz C, Jacot W, et al
   Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer.
   BMC Cancer. 2025;25:1801.
   PubMed         Abstract available
   
   

   
   BMC Neurol

8. QUAN M, Ren F, Sun T, Chang X, et al
   Adenylate kinase 5 autoimmune encephalitis following craniopharyngioma radiotherapy.
   BMC Neurol. 2026 Jun 25. doi: 10.1186/s12883-026-05090.
   PubMed         Abstract available
   
   

   
   Cancer

9. WU B, Zhang Z, Ma H, Huang J, et al
   Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O(6)-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
   Cancer. 2026;132:e70502.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

10. MISHRA A, Golub D, Kashanian A, Unadkat P, et al
    Laser interstitial thermal therapy for the ablation of pediatric low-grade glioma: a single-institution series of 13 patients.
    Childs Nerv Syst. 2026;42:262.
    PubMed         Abstract available
    
    
11. DONG X, Xiong J, Liu L, Xu R, et al
    Giant cystic intraventricular schwannoma with chronic haemorrhage in an adolescent: diagnostic pitfalls and targeted literature review.
    Childs Nerv Syst. 2026;42:263.
    PubMed         Abstract available
    
    
12. NORIS A, Barucci A, Ferri E, Menegatti M, et al
    Clinical utility of [(18)F]-FET PET Imaging in pediatric brain tumors: a case series.
    Childs Nerv Syst. 2026;42:266.
    PubMed         Abstract available
    
    

    
    J Neurooncol

13. FIEDLER C, Kordes UR, Thomas C, Hasselblatt M, et al
    CPT-SIOP registry: evaluation of risk factors for disease progression in pediatric choroid plexus papilloma.
    J Neurooncol. 2025;175:333-343.
    PubMed         Abstract available
    
    
14. GAGLIARDI F, Roncelli F, Snider S, De Domenico P, et al
    Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective study.
    J Neurooncol. 2025;175:825-836.
    PubMed         Abstract available
    
    
15. ZIEBART A, Onken J, Nadji-Ohl M, Jungk C, et al
    Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry.
    J Neurooncol. 2025;176:14.
    PubMed         Abstract available
    
    
16. TINI P, Novi F, Donnini F, Perrella A, et al
    Assessing ChatGPT-4 as a clinical decision support tool in neuro-oncology radiotherapy: a prospective comparative study.
    J Neurooncol. 2025;176:13.
    PubMed         Abstract available
    
    
17. PRICE M, Ballard CAP, Waite KA, Ostrom QT, et al
    Using data for novel discoveries in neuro-oncology research.
    J Neurooncol. 2025;176:30.
    PubMed         Abstract available
    
    
18. ANEMAWU B, Tirist A, Mohamedsaid A, Belay SA, et al
    The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study.
    J Neurooncol. 2025;176:49.
    PubMed         Abstract available
    
    
19. ZHANG W, Cao K, Zhang X, Cao N, et al
    Potential clinical value of circulating tumor cells in predicting progression for atypical teratoid rhabdoid tumor in young children.
    J Neurooncol. 2025;176:51.
    PubMed         Abstract available
    
    
20. MAHDI J, Gust JA, Vitanza NA, Scott B, et al
    Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review.
    J Neurooncol. 2025;176:60.
    PubMed         Abstract available
    
    
21. ALBARRACIN CARDENAS CI, Caballero Rojas H, Ochoa Vera ME, Luna Gonzalez ML, et al
    Survival of nervous system tumors in a Colombian population cancer registry.
    J Neurooncol. 2025;176:84.
    PubMed         Abstract available
    
    
22. COWAN D, Lopez-Rivera V, Akinwunmi-Williams T, Jani J, et al
    Timing of complications following stereotactic brain biopsy: implications for same-day discharge feasibility.
    J Neurooncol. 2025;176:91.
    PubMed         Abstract available
    
    
23. CHO WJ, Choi K, Han K, Choi SH, et al
    Clinical and molecular characteristics and prognostic factors of diffuse astrocytoma, IDH-wildtype, not elsewhere classified.
    J Neurooncol. 2025;176:103.
    PubMed         Abstract available
    
    
24. KITYA D, Ssembatya JM, Taremwa BM, Adil SM, et al
    Descriptive epidemiology and surgical outcomes of intracranial tumors in southwestern uganda: a cross-sectional study.
    J Neurooncol. 2025;176:107.
    PubMed         Abstract available
    
    
25. KITE T, Harikumar N, Jaffee S, Knox H, et al
    A systematic review of stereotactic radiosurgery for pituitary metastases.
    J Neurooncol. 2026;176:174.
    PubMed         Abstract available
    
    
26. BARBE-RICHAUD JB, Cebula H, Todeschi J, Santin MDN, et al
    From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.
    J Neurooncol. 2026;178:73.
    PubMed         Abstract available
    
    
27. KAPITANCUKE M, Petroska D, Petrosiute A, Luciunaite A, et al
    Expression patterns of carbonic anhydrase IX and immune response biomarkers in pediatric gliomas and glioneuronal tumors.
    J Neurooncol. 2026;178:75.
    PubMed         Abstract available
    
    
28. AKKARA Y, Wang PP, Hon JJ, Egrilmezer A, et al
    Perioperative determinants of oncologic trajectory shaping recurrence and survival following resection of brain metastases.
    J Neurooncol. 2026;178:76.
    PubMed         Abstract available
    
    
29. HONG Y, Jiang R, Chen S, Lu D, et al
    Survival outcomes and a prognostic nomogram in EGFR-mutant non-small cell lung cancer with leptomeningeal metastasis: a real-world cohort study.
    J Neurooncol. 2026;178:80.
    PubMed         Abstract available
    
    
30. SAMPATH SG, Tang AJ, Chen AX, Viswanathan A, et al
    Correction to: cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes.
    J Neurooncol. 2026;178:79.
    PubMed        
    
    
31. DATTA A, Pandey A, Verma R, Jaiswal AK, et al
    Integrated serum and tissue NMR metabolomics with correlation analysis reveals metabolic alterations in gliomas.
    J Neurooncol. 2026;178:77.
    PubMed         Abstract available
    
    
32. VAN DE LANGERIJT ON, Ehret F, Niemierko A, Oh KS, et al
    Long-term outcomes and late effects of surgery and radiotherapy in adult intracranial ependymoma patients.
    J Neurooncol. 2026;178:78.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

33. FIOCCHI A, Rushing EJ, Brandt S, Kloepper J, et al
    Novel YWHAE-NTRK3 fusion in a pediatric glioma.
    J Neuropathol Exp Neurol. 2026 Jun 26:nlag065. doi: 10.1093.
    PubMed        
    
    

    
    J Neurosurg

34. LAAJAVA J, Niemela M, Korja M
    Association between persisting peritumoral brain edema and seizures as well as worse functional outcome after meningioma surgery: a retrospective study of 218 patients.
    J Neurosurg. 2026 Jun 19:1-10. doi: 10.3171/2026.1.JNS252864.
    PubMed         Abstract available
    
    
35. WANG SY, Bowden SG, Reiner AS, Toth AJ, et al
    Resection plus stereotactic radiosurgery versus stereotactic radiosurgery alone and control of brain metastasis-induced seizures.
    J Neurosurg. 2026 Jun 26:1-14. doi: 10.3171/2026.1.JNS251792.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

36. 
    Corrigendum to: Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma.
    Neuro Oncol. 2026 Jun 26:noag140. doi: 10.1093.
    PubMed        
    
    
37. GROVES A, Kirkland OO, Cascio CL, Wang X, et al
    Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma.
    Neuro Oncol. 2026 Jun 25:noag142. doi: 10.1093.
    PubMed         Abstract available
    
    
38. NG HK
    The critical issue of grade 2 vs grade 3 in IDH-mutant gliomas.
    Neuro Oncol. 2026 Jun 23:noag143. doi: 10.1093.
    PubMed        
    
    
39. DIMOVA L, Stritzelberger J, Dimov D, Ort J, et al
    Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival.
    Neuro Oncol. 2026 Jun 19:noag134. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

40. DA SILVA AMP, Goncalves OR, Tudella GCN, Menegucci G, et al
    Efficacy and Safety of Perampanel in Patients With Brain Tumor-Related Epilepsy: A Systematic Review and Meta-Analysis.
    Neurol Clin Pract. 2026;16:e200636.
    PubMed         Abstract available
    
    

    
    Neuroradiology

41. CALANDRELLI R, Pilato F, D'Apolito G, De Lucia D, et al
    Predictors of residual and recurrent pituitary neuroendocrine tumors: impact of medial cavernous sinus wall invasion and Trouillas grading.
    Neuroradiology. 2025;67:1953-1963.
    PubMed         Abstract available
    
    
42. XU R, Kukun H, Xue J, Xiong Y, et al
    A predictive model for differentiating PFA and PFB subtypes of posterior fossa ependymoma using multi-sequence MRI radiomics: a two-center study.
    Neuroradiology. 2025 Oct 23. doi: 10.1007/s00234-025-03823.
    PubMed        
    
    

    
    Neurosurgery

43. TOS SM, Hajikarimloo B, Mantziaris G, Cassimatis ND, et al
    Dose De-escalation in Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients on Concurrent Immunotherapy or Targeted Therapy: A Multicenter Experience.
    Neurosurgery. 2026 Jun 25. doi: 10.1227/neu.0000000000004138.
    PubMed         Abstract available
    
    
44. AL-ADLI NN, Ehret F, Nguyen MP, Choudhury A, et al
    Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular Subgroups.
    Neurosurgery. 2026 Jun 25. doi: 10.1227/neu.0000000000004140.
    PubMed         Abstract available
    
    
45. TONG D, Shor D, Zhang B, Ruschin M, et al
    First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous Radiosurgery.
    Neurosurgery. 2026 Jun 26. doi: 10.1227/neu.0000000000004142.
    PubMed         Abstract available
    
    

    
    PLoS One

46. WANG B, An Y, Shu Y, Cheng X, et al
    Integrated single-cell RNA sequencing and Bulk-RNA technologies reveal the immunological characteristics of lactylation related-genes in glioblastoma.
    PLoS One. 2026;21:e0351849.
    PubMed         Abstract available
    
    
47. DU J, Yang L, Zhang D, Wang J, et al
    A multimodal ConvNeXt-Tiny deep learning model for simultaneous prediction of IDH mutation and Ki-67 expression in gliomas.
    PLoS One. 2026;21:e0351757.
    PubMed         Abstract available
    
    
48. LU H, Wang Y, Xue H, Wang G, et al
    GL-Net: A knowledge-guided Gaussian-gated and layered refinement network for 3D MRI segmentation of brain gliomas.
    PLoS One. 2026;21:e0351953.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum